Comparison of Ticagrelor and Clopidogrel in Elective Coronary Stenting: A Double Blind Randomized Clinical Trial

Comparison of Ticagrelor and Clopidogrel in Elective Coronary Stenting: A Double Blind Randomized Clinical Trial

Background. Dual antiplatelet therapy with a P2Y12 inhibitor (e.g., clopidogrel and ticagrelor) and aspirin is recommended for at least one year after percutaneous coronary intervention (PCI) to prevent further myocardial infarction and stent thrombosis as the major adverse effects of PCI. Methods....

Full description

Bibliographic Details
Main Authors:	Mohammadjavad Mehdizadeh Parizi, Reza Golchin Vafa, Amin Ahmadi, Reza Heydarzade, Mehrdad Sadeghi, Amin Khademolhossseini, Farhang Amiri, Soroush Khoshnood Mansorkhani, Ali Tavan, Nazanin Hosseini, Mohammad Montaseri, Seyed Ali Hosseini, Javad Kojuri
Format:	Article
Language:	English
Published:	Hindawi-Wiley 2023-01-01
Series:	Journal of Interventional Cardiology
Online Access:	http://dx.doi.org/10.1155/2023/5544440

Similar Items

The long-term effects of the Covid-19 infection on cardiac symptoms
by: Reza Golchin Vafa, et al.
Published: (2023-06-01)

Evaluation the effects of red yeast rice in combination with statin on lipid profile and inflammatory indices; a randomized clinical trial
by: Ali Tavan, et al.
Published: (2022-11-01)

Effects of High- or Moderate-intensity Rosuvastatin on 1-year Major Adverse Cardiovascular Events Post-percutaneous Coronary Intervention
by: Morteza Chehrevar, et al.
Published: (2022-11-01)

Stent thrombosis during COVID‐19 pandemic: A case series
by: Mohammad Montaseri, et al.
Published: (2022-05-01)

Ticagrelor versus clopidogrel in the management of acute myocardial infarction
by: Candice Volney, et al.
Published: (2019-07-01)

Cost-Effectiveness Comparison between Ticagrelor and Clopidogrel in Acute Coronary Syndrome in Iran
by: Amir Hashemi-meshkini, et al.
Published: (2023-04-01)

Cost-effectiveness of Platelet Function-Guided Strategy with Clopidogrel or Ticagrelor
by: Nikita Lomakin, et al.
Published: (2019-12-01)

Ticagrelor versus clopidogrel for recurrent myocardial infarction: An outcomes-based agreement
by: Samuel K. Peasah, et al.
Published: (2023-12-01)

Comparison of Ticagrelor and Clopidogrel for Patients Undergoing Emergency Percutaneous Coronary Intervention
by: Bin YANG, et al.
Published: (2018-07-01)

Real‐World Comparison of Ticagrelor and Clopidogrel: Rosetta Stone or Lost in Translation?
by: Brian A. Bergmark
Published: (2020-07-01)

Comparison of ticagrelor with clopidogrel on quality of life in patients with acute coronary syndrome
by: Hyeyeon Moon, et al.
Published: (2021-10-01)

Optimal strategy of switching from clopidogrel to ticagrelor in Chinese acute coronary syndrome patients with complicated coronary artery disease: the switching from clopidogrel to ticagrelor (SHIFT-CACS) study
by: Ying Yao, et al.
Published: (2019-10-01)

A comparative pharmacodynamic study of ticagrelor versus clopidogrel and ticagrelor in patients undergoing primary percutaneous coronary intervention: the CAPITAL RELOAD study.
by: Benjamin Hibbert, et al.
Published: (2014-01-01)

The Comparison of the Initial TIMI Flow Grade in Acute ST-Elevation Myocardial Infarction Patients Receiving Ticagrelor vs. Clopidogrel before Undergoing Primary Percutaneous Coronary Intervention: A Prospective Cohort Study
by: Amin Elahifar, et al.
Published: (2024-01-01)

In-stent thrombosis when switching ticagrelor to clopidogrel after percutaneous coronary intervention
by: Aaron E. Brice, et al.
Published: (2017-04-01)

Cost-effectiveness of ticagrelor and generic clopidogrel in patients with acute coronary syndrome in Switzerland
by: David Gasche, et al.
Published: (2013-09-01)

Assessment of myocardial salvage in patients with STEMI undergoing thrombolysis: ticagrelor versus clopidogrel
by: Stylianos Petousis, et al.
Published: (2022-07-01)

Cost-effectiveness of ticagrelor versus clopidogrel in patients with acute coronary syndromes in Canada
by: Grima DT, et al.
Published: (2014-01-01)

Ticagrelor Is Superior to Clopidogrel in Inhibiting Platelet Reactivity in Patients With Minor Stroke or TIA
by: Yingying Yang, et al.
Published: (2020-06-01)

The effect of antiplatelet drug on coronary endothelial and microvascular function: comparison with ticagrelor and clopidogrel
by: Woong Gil Choi, et al.
Published: (2021-03-01)

Effect of Ticagrelor Versus Clopidogrel on Aortic Stiffness in Patients With Coronary Artery Disease
by: Charalambos Vlachopoulos, et al.
Published: (2019-06-01)

Abstract 053: Reduced‐Dose Ticagrelor Versus Full‐Dose Ticagrelor Versus Clopidogrel In Acute Stroke Management: A Retrospective Cohort Study
by: Harsh Desai, et al.
Published: (2023-11-01)

INFLUENCE OF SWITCHING OF CLOPIDOGREL TO TICAGRELOR ON THE DEVELOPMENT OF CARDIOVASCULAR EVENTS IN PATIENTS WITH ST SEGMENT ELEVATION
by: E. V. Tavlueva, et al.
Published: (2017-11-01)

Ticagrelor versus clopidogrel after intracranial stent angioplasty: a real-world study
by: Lili Sun, et al.
Published: (2023-08-01)

Differential modulation of polyunsaturated fatty acids in patients with myocardial infarction treated with ticagrelor or clopidogrel
by: Karla N. Samman, et al.
Published: (2021-06-01)

Compared efficacy of clopidogrel and ticagrelor in treating acute coronary syndrome: a meta-analysis
by: Dong Wang, et al.
Published: (2018-11-01)

No Differences in Gastrointestinal Bleeding Risk among Clopidogrel-, Ticagrelor-, or Prasugrel-Based Dual Antiplatelet Therapy
by: Viviana Laredo, et al.
Published: (2020-05-01)

Switching Ticagrelor to 600 mg or 300 mg Clopidogrel Loading Bridge in Patients with Unstable Angina
by: Sinem Cakal, et al.
Published: (2021-06-01)

Ticagrelor versus clopidogrel in East Asian patients with acute coronary syndrome: A meta-analysis
by: He Meijiao, et al.
Published: (2022-02-01)

Efficacy and safety outcomes of ticagrelor compared with clopidogrel in Chinese elderly patients with acute coronary syndrome
by: Wang HD, et al.
Published: (2016-07-01)

Efficacy and safety of ticagrelor versus clopidogrel in patients with non-ST-elevation myocardial infarction in Taiwan
by: Chih-Kuo Lee, et al.
Published: (2021-07-01)

Efficacy and Safety of Ticagrelor in Comparison to Clopidogrel in Elderly Patients With ST‐Segment–Elevation Myocardial Infarctions
by: Johannes Schmucker, et al.
Published: (2019-09-01)

Ticagrelor, but Not Clopidogrel, Attenuates Hepatic Steatosis in a Model of Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Eun Jeoung Lee, et al.
Published: (2024-03-01)

The Effect of Ticagrelor for Endovascular Intervention of Intracranial Aneurysm Patients with or without Clopidogrel Resistant: A Meta-Analysis
by: Pengfei Xia, et al.
Published: (2022-08-01)

The effect of ticagrelor and clopidogrel on angiographic parameters according to diabetic status in patients with ST elevation myocardial infarction
by: F. Aydınyılmaz, et al.
Published: (2022-09-01)

Comparing the effectiveness and safety of dual antiplatelet with ticagrelor or clopidogrel in elderly Asian patients with acute myocardial infraction
by: Jong-Shiuan Yeh, et al.
Published: (2023-03-01)

Does the level of myocardial injury differ in primary angioplasty patients loaded first with clopidogrel and the ones with ticagrelor?
by: Nil Ozyuncu, et al.
Published: (2020-07-01)

Randomized Trial Comparing the Effects of Ticagrelor Versus Clopidogrel on Myocardial Perfusion in Patients With Coronary Artery Disease
by: Matthieu Pelletier‐Galarneau, et al.
Published: (2017-05-01)

Comparison of Clinical Outcomes Between Ticagrelor and Clopidogrel in Acute Coronary Syndrome: A Comprehensive Meta-Analysis
by: Mengyi Sun, et al.
Published: (2022-01-01)

The Effect of Ticagrelor on Endothelial Function Compared to Prasugrel, Clopidogrel, and Placebo: A Systematic Review and Meta-Analysis
by: Baoyi Guan, et al.
Published: (2022-01-01)